The Role of Whole Genome Gene Expression Studies in Deciphering Cortical Grey Matter Pathology in Multiple Sclerosis
Received Date: Jan 11, 2021 / Accepted Date: Jan 25, 2021 / Published Date: Feb 01, 2021
Abstract
The chronic cortical pathology of Multiple Sclerosis (MS) composes of demyelination and neurodegeneration and has been studied since the early pathoanatomical descriptions of MS. Due to technical difficulties in detecting the extent of cortical damage accumulating during the disease process; it has only been recognized as a major aspect of MS pathology 20 years ago. Whole genome gene expression studies from cortical human brain tissue have been an invaluable tool to gain novel insights into the molecular pathology of the so-called normal-appearing cortical grey matter and demyelinated grey matter lesions and have aided in discovering new pathomechanisms. These studies however are notoriously difficult to perform and interpret, due to the heterogeneity of the disease itself and the complex architecture of the human brain cortex.
Keywords: Cortical grey matter; Molecular pathology; RNA expression; Genome; Gene expression
Citation: Enz LS, Jaggi S, Huemer P, Schaeren-Wiemers N (2021) The Role of Whole Genome Gene Expression Studies in Deciphering Cortical Grey Matter Pathology in Multiple sclerosis. J Clin Exp Neuroimmunol. 6: 125. Doi: 10.4172/jceni.1000125
Copyright: © 2021 Enz LS et al. This is an open-access article distributed under the terms of the creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 2038
- [From(publication date): 0-2021 - Apr 20, 2024]
- Breakdown by view type
- HTML page views: 1454
- PDF downloads: 584
